cetuximab
Showing 1 - 25 of 506
Cancer of Colon Trial in Jerusalem (Cetuximab)
Terminated
- Cancer of Colon
- Cetuximab
-
Jerusalem, IsraelHadassah Ein Kerem
Aug 2, 2022
Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston
Active, not recruiting
- Metastatic Colorectal Carcinoma
- +4 more
- Cetuximab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 4, 2022
Advance NSCLC Trial (GFH925, Cetuximab)
Not yet recruiting
- Advance Non-small Cell Lung Cancer
- GFH925
- Cetuximab
- (no location specified)
Mar 7, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- Capecitabine
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,
Not yet recruiting
- Colon Adenocarcinoma
- +4 more
- Encorafenib
- +5 more
- (no location specified)
Jan 24, 2023
Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)
Not yet recruiting
- Colon Cancer
- Colorectal Cancer
- MRTX849
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
HNSCC Trial in Lorient (Cetuximab, avelumab, Cisplatin)
Active, not recruiting
- HNSCC
- Cetuximab
- +3 more
-
Lorient, FranceCentre Hospitalier Bretagne Sud
Mar 10, 2022
HPV-unrelated Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Palbociclib, Cetuximab)
Recruiting
- HPV-unrelated Head and Neck Squamous Cell Carcinoma
- Palbociclib
- Cetuximab
-
Saint Louis, MissouriWashington University School of Medicine
Apr 7, 2022
Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)
Active, not recruiting
- Treatment Related Cancer
- 5-FU
- +4 more
-
Munich, GermanyLudwig Maximilians University
Jan 19, 2022
Colorectal Cancer Trial in Salt Lake City (Cetuximab)
Recruiting
- Colorectal Cancer
- Cetuximab
-
Salt Lake City, Utah
- +1 more
May 3, 2022
Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Avelumab
- +2 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Feb 16, 2022
Metastatic Colorectal Cancer Trial in Munich (Irinotecan, Folinic Acid, 5-FU)
Recruiting
- Metastatic Colorectal Cancer
- Irinotecan
- +8 more
-
Munich, GermanyKlinikum der Universitaet Muenchen - Campus Grosshadern
Dec 2, 2021
Head Neck Cancer, Squamous Cell Carcinoma Trial in London (Avelumab, Cetuximab)
Active, not recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma
- Avelumab
- Cetuximab
-
London, United KingdomUniversity College Hospital
May 17, 2022
Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)
Terminated
- Colorectal Neoplasms
- bevacizumab
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 30, 2021
Microsatellite Stable Metastatic Colorectal Cancer Trial in Tucson, Aurora, New Brunswick (ALX148, Cetuximab, Pembrolizumab)
Recruiting
- Microsatellite Stable Metastatic Colorectal Cancer
- ALX148
- +2 more
-
Tucson, Arizona
- +2 more
Jul 28, 2022
Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)
Recruiting
- Cancer of the Colon
- +4 more
- Cetuximab
- Palbociclib
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022
Metastatic Colorectal Cancer Trial in Munich (Bevacizumab, Irinotecan, Folinic acid)
Active, not recruiting
- Metastatic Colorectal Cancer
- Bevacizumab
- +5 more
-
Munich, GermanyKlinikum der Universitaet Muenchen
Dec 2, 2021
Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Cetuximab, Stereotactic radiosurgery)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- Cetuximab
- Stereotactic radiosurgery
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute
Feb 10, 2022
Colorectal Cancer Trial in Nanjing (Raltitrexed, Cetuximab)
Recruiting
- Colorectal Cancer
- Raltitrexed
- Cetuximab
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Institute & Hospital
Aug 27, 2021
Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic Trial in Chicago (VS-6766, Cetuximab, Pill Diary)
Not yet recruiting
- Colorectal Cancer
- +4 more
- VS-6766
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Jan 6, 2022
Colon Cancer, Resected Stage Trial in Houston (Cetuximab, CB-NK-TGF-βR2-/NR3C1, Fludarabine phosphate)
Recruiting
- Colon Cancer
- Resected Stage
- Cetuximab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 23, 2022
Carcinoma, Squamous Cell of Head and Neck Trial in Darmstadt (Cetuximab, Cisplatin/Carboplatin, 5-fluorouracil)
Completed
- Carcinoma, Squamous Cell of Head and Neck
- Cetuximab
- +2 more
-
Darmstadt, GermanyResearch site
Apr 19, 2022
Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)
Recruiting
- Squamous Cell Cancers of the Head and Neck
- cetuximab
- afatinib
-
New Haven, ConnecticutYale Cancer Center
Feb 10, 2022